MedTrace Logo

Novel Approaches to Reducing Tobacco Related Harm

NCT02600273 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-09-30

No results posted yet for this study

Summary

The purpose of this study is to assess initial reactions to alternative nicotine/tobacco products among smokers living with HIV.

Conditions

  • Smoking
  • Tobacco Smoking Behavior
  • Cigarette Smoking

Interventions

OTHER

Usual brand cigarettes

Usual brand cigarettes

OTHER

Lower nicotine content cigarettes

SPECTRUM research cigarettes

OTHER

Electronic cigarettes 1

Electronic cigarette with 0 g/mL e-liquid

OTHER

Electronic cigarettes 2

Electronic cigarette with 18 g/mL e-liquid

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • F. Joseph McClernon, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02600273 on ClinicalTrials.gov